Jim Datin

Jim Datin

Direktor/Vorstandsmitglied bei ORASURE TECHNOLOGIES, INC.

Vermögen: 432 088 $ am 30.04.2024

61 Jahre
Health Technology
Finance
Technology Services

Profil

Mr. Jim A.
Datin
is an Operating Partner at GHO Capital Partners LLP, an Independent Director at OraSure Technologies, Inc., a Chief Executive Officer & Director at BALX Holdings LLC and a Co-Managing Director at BioAgilytix Europe GmbH.
He is on the Board of Directors at OraSure Technologies, Inc., The North Carolina Biotechnology Center, BALX Holdings LLC, Celerant Consulting, Inc., Hepatitis B Foundation and Life Sciences Pennsylvania.
Mr. Datin was previously employed as an Independent Director by FSD Pharma, Inc., a Non-Executive Director by BioAgilytix Labs LLC, an Independent Director by NuPathe, Inc., a Vice Chairman by University City Science Center, an Executive Vice President & Managing Director by Safeguard International Management LLC, an EVP & Managing Director-Life Sciences Group by Safeguard Scientifics, Inc., a Chairman by Clarient, Inc., a Chief Executive Officer by TouchPoint Solutions, a Group President by Dendrite International, Inc., a Group Director-Corporate Business Strategy by GlaxoSmithKline, Inc., a Chief Executive Officer by Golden Land Bhd., a Director-International Business by Baxter Corp., a Member by Ben Franklin Technology Partners /Ventures/, a Chairman by Laureate Biopharmaceutical Services, Inc., a Director-International Business by Merck KGaA, and a Group Director by Smithkline Beckman Corp.
He also served on the board at Acelerate, Inc., Intralinks Holdings, Inc., NovaSom, Inc., Putney, Inc., Rubicor Medical, Inc., Sotera Wireless, Inc. and Ventaira Pharmaceuticals, Inc. He received his undergraduate degree from Marshall University, an undergraduate degree from The Wharton School of the University of Pennsylvania and an MBA from the University of New Haven.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
14.05.2024 82 146 ( 0,11% ) 432 088 $ 30.04.2024

Aktive Positionen von Jim Datin

UnternehmenPositionBeginn
ORASURE TECHNOLOGIES, INC. Direktor/Vorstandsmitglied 11.08.2019
Hepatitis B Foundation Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 01.01.2017
Vorstandsvorsitzender -
Vorstandsvorsitzender -
Private Equity Investor 01.03.2023
Alle aktiven Positionen von Jim Datin

Ehemalige bekannte Positionen von Jim Datin

UnternehmenPositionEnde
Vorstandsvorsitzender 16.06.2022
░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Jim Datin im Detail an

Ausbildung von Jim Datin

University of New Haven Masters Business Admin
Marshall University Undergraduate Degree
The Wharton School of the University of Pennsylvania Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jim Datin im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

34

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen5
SAFEGUARD SCIENTIFICS, INC.

Finance

GOLDEN LAND

Finance

MERCK KGAA

Health Technology

ORASURE TECHNOLOGIES, INC.

Health Technology

FSD PHARMA INC.

Health Technology

Private Unternehmen26

Technology Services

Health Services

Miscellaneous

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Finance

Finance

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Technology Services

Technology Services

Hepatitis B Foundation

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Sehen Sie sich die Unternehmensverbindungen an
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT